Search Results - "Croom, D K"
-
1
Dietary fat alters HIV protease inhibitor-induced metabolic changes in mice
Published in The Journal of nutrition (01-09-2000)“…Human immunodeficiency virus (HIV) protease inhibitors (PI) may alter lipid metabolism in patients with acquired immunodeficiency syndrome (AIDS). However, the…”
Get more information
Journal Article -
2
Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists
Published in Journal of medicinal chemistry (15-08-1997)“…We previously described a series of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepine CCK-A agonists exemplified by compound 1 (GW 5823), which is the first…”
Get full text
Journal Article -
3
HIV Protease Inhibitors Stimulate Hepatic Triglyceride Synthesis
Published in Arteriosclerosis, thrombosis, and vascular biology (01-12-2000)“…Abstract—Hyperlipidemia may complicate the use of HIV protease inhibitors (PIs) in AIDS therapy. To determine the cause of hyperlipidemia, the effect of PIs on…”
Get full text
Journal Article -
4
Water Soluble Inhibitors of Topoisomerase I: Quaternary Salt Derivatives of Camptothecin
Published in Journal of medicinal chemistry (02-02-1996)“…Eleven water soluble 7-substituted quaternary ammonium salt derivatives of 10,11-(methylenedioxy)- and 10,11-(ethylenedioxy)-(20S)-camptothecin were…”
Get full text
Journal Article -
5
3-[2-(N-Phenylacetamide)]-1,5-benzodiazepines: Orally Active, Binding Selective CCK-A Agonists
Published in Journal of medicinal chemistry (19-07-1996)“…A series of modifications were made to the C-3 substituent of the 1,5-benzodiazepine CCK-A agonist 1. Replacement of the inner urea NH and addition of a methyl…”
Get full text
Journal Article -
6
Modification of Receptor Selectivity and Functional Activity in Cholecystokinin Peptoid Ligands
Published in Journal of medicinal chemistry (01-08-1995)“…Hybrid analogs of the cholecystokinin A (CCK-A) receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (1,A-71623) and the CCK-B receptor…”
Get full text
Journal Article -
7
Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity (II): Optimization of the C3 Amino Substituent
Published in Journal of medicinal chemistry (20-12-1996)“…Analogs of the previously reported 1,5-benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonist 1 were prepared which explore substitution and/or…”
Get full text
Journal Article -
8
-
9
Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”
Published in Journal of medicinal chemistry (19-01-1996)“…Directed screening of compounds selected from the Glaxo registry file for contractile activity on the isolated guinea pig gallbladder (GPGB) identified a…”
Get full text
Journal Article -
10
1,4-Benzodiazepine Peripheral Cholecystokinin (CCK-A) Receptor Agonists
Published in Bioorganic & medicinal chemistry letters (07-05-2001)“…A series of 1,4-benzodiazepines, N-1-substituted with an N-isopropyl- N-phenylacetamide moiety, was synthesized and screened for CCK-A agonist activity. In…”
Get full text
Journal Article -
11
3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A Agonists That Demonstrate Oral Activity as Satiety Agents
Published in Journal of medicinal chemistry (05-07-1996)Get full text
Journal Article -
12
Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments
Published in Biochemical and biophysical research communications (05-11-2004)“…Dipeptidyl peptidase-IV (DPP-IV) regulates metabolism by degrading incretins involved in nutritional regulation. Metformin and pioglitazone improve insulin…”
Get full text
Journal Article -
13
-
14
Structure-activity relationships for inhibition of type 1 and 2 human 5α-reductase and human adrenal 3β-hydroxy-Δ5-steroid dehydrogenase/3-keto-Δ5-steroid isomerase by 6-azaandrost-4-en-3-ones : optimization of the C17 substituent
Published in Journal of medicinal chemistry (1995)Get full text
Journal Article